Vancomycin intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia

被引：0
|
作者：
Anderson, D
Naimi, TS
O'Boyle, C
Boxrud, DJ
Johnson, S
Tenover, FC
Lynfield, R
机构：
[1] Abbott NW Hosp, Wayzata, MN USA
[2] Minnesota Dept Hlth, Minneapolis, MN USA
[3] CDC, Atlanta, GA 30333 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2001年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
13
引用
收藏
页码：1090 / 1090
页数：1
相关论文
共 50 条
  • [31] Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia
    Yeh, Yen-Cheng
    Yeh, Kuo-Ming
    Lin, Te-Yu
    Chiu, Sheng-Kang
    Yang, Ya-Sung
    Wang, Yung-Chih
    Lin, Jung-Chung
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2012, 45 (03) : 214 - 220
  • [32] Predictors of Relapse of Methicillin-Resistant Staphylococcus Aureus Bacteremia After Vancomycin Treatment
    Welsh, K. J.
    Skrobarcek, K. A.
    Abbott, A. N.
    Lewis, C. T.
    Kruzel, M. C.
    Lewis, E. M.
    Armitige, L. Y.
    Wanger, A.
    ANNALS OF EMERGENCY MEDICINE, 2011, 58 (04) : S219 - S220
  • [33] Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia
    Sakoulas, G
    Gold, HS
    Cohen, RA
    Venkataraman, L
    Moellering, RC
    Eliopoulos, GM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) : 699 - 704
  • [34] Predictors of Relapse of Methicillin-Resistant Staphylococcus aureus Bacteremia after Treatment with Vancomycin
    Welsh, Kerry J.
    Skrobarcek, Kimberly A.
    Abbott, April N.
    Lewis, Cole T.
    Kruzel, Mark C.
    Lewis, Evan M.
    Gardiner, Jeanelle M.
    Mohr, John F.
    Armitige, Lisa Y.
    Wanger, Audrey
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (10) : 3669 - 3672
  • [35] Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
    Liang, Jin
    Hu, Yuanfang
    Fu, Mingxia
    Li, Na
    Wang, Fengxia
    Yu, Xiaojun
    Ji, Bing
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 379 - 388
  • [36] Effect of Reduced Vancomycin Susceptibility on Clinical and Economic Outcomes in Staphylococcus aureus Bacteremia
    Han, Jennifer H.
    Mascitti, Kara B.
    Edelstein, Paul H.
    Bilker, Warren B.
    Lautenbach, Ebbing
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (10) : 5164 - 5170
  • [37] Microscopic polyangiitis triggered by recurrent methicillin-resistant Staphylococcus aureus bacteremia
    Rahil Kasmani
    Kelechi Okoli
    Kalpana Naraharisetty
    William Gunning
    Joseph I. Shapiro
    Shobha Ratnam
    International Urology and Nephrology, 2010, 42 : 821 - 824
  • [38] Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility
    Gardner, Stewart G.
    Marshall, Darrell D.
    Daum, Robert S.
    Powers, Robert
    Somerville, Greg A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [39] Microscopic polyangiitis triggered by recurrent methicillin-resistant Staphylococcus aureus bacteremia
    Kasmani, Rahil
    Okoli, Kelechi
    Naraharisetty, Kalpana
    Gunning, William
    Shapiro, Joseph I.
    Ratnam, Shobha
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (03) : 821 - 824
  • [40] Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus
    Kantzanou, M
    Tassios, PT
    Tseleni-Kotsovili, A
    Legakis, NJ
    Vatopoulos, AC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) : 729 - 731
12345